PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Vita Mojo is an award winning food technology company, providing affordable meals tailored specifically to the customer. The food is personal and transparent as to what goes into each dish and how it was prepared. All ingredients are picked to suit your own tastes and needs, and can be personalised to increase your protein or decrease your calories as required.
days to go:
Expired
investment:
£3,200,080
Solo Coffee is a company founded by Theo & Alex, aiming to simplify the world of specialty coffee. They've achieved £1.17 million in revenue for the financial year ending in April 2023 and break-even in March 2023 by producing espresso-strength cold brew coffee concentrate, which is used in various coffee applications, and they are now raising funds to support further growth in the rapidly growing Ready to Drink coffee market.
Solo Coffee's Coffee Concentrate has gained popularity, with over 7 million servings sold since its launch in October 2020. It is used in numerous bars in the UK and is one of the top 3 most sold chilled coffees on Amazon UK. The company is expanding its manufacturing to the US and targeting various channels, including foodservice, on-trade, retail, and direct-to-consumer, to make coffee preparation easier in different settings.
days to go:
Expired
investment:
£478,639
Redchurch Brewery have previously successfully raised on Crowdcube, expanding with a 30 barrel brew house in Harlow and rebranding, which secured listings in Waitrose and M&S. With their next raise they will be looking to invest in faster packaging, increasing staff and delivery vehicles, and adding further fermentation vessels to increase production to more than 1.3 million litres annually which is around 2.3 million pints of beer.
days to go:
Expired
investment:
£395,760
FullClear is an advanced beer line cleaning solution. It is non-toxic and non-corrosive. It is proven to be 96.7% more effective than current chemicals.
days to go:
Expired
investment:
£248,860
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
One Planet Pizza aim to provide the UK with a range of high quality vegan frozen pizza. One Planet's pizza currently come in 4 Italian style pizza's and can be found in most of the major high street supermarkets.
days to go:
Expired
investment:
£26,824
Rebel Book Club is a developing subscription business of six hundred members who have read fifty-two books in four years. It delivers one non-fiction book every month and hosts a secret meetup featuring a book-inspired cocktail. The company has 600+ paying members in London, Bristol and Oxford, etc. and it receives 130+ average number of new applications monthly. The company hosts meetups at Entrepreneur First, Airbnb HQ, and WeWork. Rebel Book Club has collaborated with authors Matthew Syed (Rebel ideas), Kate Raworth (Doughnut Economics), Seth Godin (This is Marketing) and many more. The company aims to make the world's best non-fiction book club by growing a membership experience, build a reach code and support literacy projects.
days to go:
Expired
investment:
£148,070
